The use of calcium hydroxyapatite in aesthetic medicine – properties, mechanism of action, and clinical safety
DOI:
https://doi.org/10.12775/QS.2025.48.66989Keywords
calcium hydroxylapatite, CaHA, aesthetic medicine, dermal fillers, biostimulation, collagen stimulation, neocollagenesis, soft tissue augmentation, skin rejuvenation, facial volumization, tissue regeneration, injectable treatments, clinical efficacy, safety profileAbstract
Background:
Aesthetic medicine has advanced rapidly, with dermal fillers becoming essential for facial rejuvenation and contouring. Among biostimulatory fillers, calcium hydroxylapatite (CaHA) is widely studied for its volumizing effect, regenerative potential, and long-lasting results.
Aim:
This paper reviews CaHA in aesthetic medicine, covering its properties, biodegradability, biocompatibility, mechanism of action, clinical applications, injection techniques, and safety.
Methods:
Clinical studies, histologic analyses, in vitro research, and systematic reviews were examined to assess CaHA’s effects on tissue remodeling, collagen production, and treatment outcomes.
Results:
CaHA consists of microspheres in a carboxymethylcellulose gel, providing immediate volume and stimulating neocollagenesis. Studies show increased type I and III collagen, fibroblast activity, and extracellular matrix improvements. Clinically, it effectively treats nasolabial folds, marionette lines, midface volume loss, neck and décolleté laxity, hand rejuvenation, and certain scars. Diluted forms are useful in thin skin areas. Adverse reactions are mostly mild and temporary; serious events are rare and usually technique-related.
Conclusions:
CaHA is a versatile biostimulatory filler offering immediate support and long-term tissue regeneration. It enhances collagen, improves skin quality, and delivers predictable, safe outcomes for facial and extrafacial rejuvenation.
References
1.Amiri M, Meçani R, Llanaj E, Niehot CD, Phillips TL, Goldie K, Kolb J, Muka T, Daughtry H. Calcium Hydroxylapatite (CaHA) and Aesthetic Outcomes: A Systematic Review of Controlled Clinical Trials. J Clin Med. 2024 Mar 14;13(6):1686. doi: 10.3390/jcm13061686. PMID: 38541911; PMCID: PMC10971119.
2.Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg. 2008 Jun;34 Suppl 1:S64-7. doi: 10.1111/j.1524-4725.2008.34245.x. PMID: 18547184.
3. The classic reprint. Concerning a subcutaneous prosthesis: Robert Gersuny. (Uber eine subcutane Prothese. Zeitschrift f. Heilkunde Wien u Leipzig 21:199, 1900.). Translated from the German by Miss Rita Euerle. Plast Reconstr Surg. 1980 Apr;65(4):525-7. PMID: 6987692.
4. González N, Goldberg DJ. Evaluating the Effects of Injected Calcium Hydroxylapatite on Changes in Human Skin Elastin and Proteoglycan Formation. Dermatol Surg. 2019 Apr;45(4):547-551. doi: 10.1097/DSS.0000000000001809. PMID: 30893178.
5. Massidda E. Starting Point for Protocols on the Use of Hyperdiluted Calcium Hydroxylapatite (Radiesse®) for Optimizing Age-Related Biostimulation and Rejuvenation of Face, Neck, Décolletage and Hands: A Case Series Report. Clin Cosmet Investig Dermatol. 2023 Nov 29;16:3427-3439. doi: 10.2147/CCID.S420068. PMID: 38050476; PMCID: PMC10693750.
6. Holzapfel AM, Mangat DS, Barron DS. Soft-tissue augmentation with calcium hydroxylapatite: histological analysis. Arch Facial Plast Surg. 2008 Sep-Oct;10(5):335-8. doi: 10.1001/archfaci.10.5.335. PMID: 18794412.
7. Hong JY, Park KY. Dual Benefits of Calcium Hydroxyapatite Filler: A Prospective Study on Midface Volume Restoration and Skin Quality Enhancement. J Cosmet Dermatol. 2025 Jun;24(6):e70265. doi: 10.1111/jocd.70265. PMID: 40439277; PMCID: PMC12121328.
8. Jacovella PF. Use of calcium hydroxylapatite (Radiesse) for facial augmentation. Clin Interv Aging. 2008;3(1):161-74. doi: 10.2147/cia.s2065. PMID: 18488886; PMCID: PMC2544361.
9. Kadouch JA. Calcium hydroxylapatite: A review on safety and complications. J Cosmet Dermatol. 2017 Jun;16(2):152-161. doi: 10.1111/jocd.12326. Epub 2017 Mar 1. PMID: 28247924.
10. Kim JE, Sykes JM. Hyaluronic acid fillers: history and overview. Facial Plast Surg. 2011 Dec;27(6):523-8. doi: 10.1055/s-0031-1298785. Epub 2011 Dec 28. PMID: 22205525.
11. Knapp TR, Kaplan EN, Daniels JR. Injectable collagen for soft tissue augmentation. Plast Reconstr Surg. 1977 Sep;60(3):398-405. PMID: 896997.
12. Loghem JV, Yutskovskaya YA, Philip Werschler W. Calcium hydroxylapatite: over a decade of clinical experience. J Clin Aesthet Dermatol. 2015 Jan;8(1):38-49. PMID: 25610523; PMCID: PMC4295857.
13. Marković S, Veselinović L, Lukić MJ, Karanović L, Bračko I, Ignjatović N, Uskoković D. Synthetical bone-like and biological hydroxyapatites: a comparative study of crystal structure and morphology. Biomed Mater. 2011 Aug;6(4):045005. doi: 10.1088/1748-6041/6/4/045005. Epub 2011 Jun 10. PMID: 21659698.
14. Marmur ES, Taylor SC, Grimes PE, Boyd CM, Porter JP, Yoo JY. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI. Dermatol Surg. 2009 Oct;35 Suppl 2:1641-5. doi: 10.1111/j.1524-4725.2009.01311.x. Epub 2009 Aug 25. PMID: 19708876.
15. McCarthy AD, Soares DJ, Chandawarkar A, El-Banna R, de Lima Faria GE, Hagedorn N. Comparative Rheology of Hyaluronic Acid Fillers, Poly-l-lactic Acid, and Varying Dilutions of Calcium Hydroxylapatite. Plast Reconstr Surg Glob Open. 2024 Aug 15;12(8):e6068. doi: 10.1097/GOX.0000000000006068. PMID: 39148505; PMCID: PMC11326459.
16.McCarthy AD, Soares DJ, Chandawarkar A, El-Banna R, Hagedorn N. Dilutional rheology of Radiesse: Implications for regeneration and vascular safety. J Cosmet Dermatol. 2024 Jun;23(6):1973-1984. doi: 10.1111/jocd.16216. Epub 2024 Feb 15. PMID: 38357772.
17. Narins RS. Minimizing adverse events associated with poly-L-lactic acid injection. Dermatol Surg. 2008 Jun;34 Suppl 1:S100-4. doi: 10.1111/j.1524-4725.2008.34250.x. PMID: 18547172.
18. Nassar A, Abou Zeid S. Complications of Calcium Hydroxyapatite in Lower Eyelid Rejuvenation: Case Report of Granuloma Formation. Plast Reconstr Surg Glob Open. 2025 Apr 10;13(4):e6681. doi: 10.1097/GOX.0000000000006681. PMID: 40212090; PMCID: PMC11984765.
19. Neuber F. Fetttransplantation. Cit Kongr Verhandl Deutsch Ges Chir. 1983;22:66.
20. Nowag B, Casabona G, Kippenberger S, Zöller N, Hengl T. Calcium hydroxylapatite microspheres activate fibroblasts through direct contact to stimulate neocollagenesis. J Cosmet Dermatol. 2023 Feb;22(2):426-432. doi: 10.1111/jocd.15521. Epub 2022 Dec 27. PMID: 36575882.
21. Pavicic T. Complete biodegradable nature of calcium hydroxylapatite after injection for malar enhancement: an MRI study. Clin Cosmet Investig Dermatol. 2015 Feb 9;8:19-25. doi: 10.2147/CCID.S72878. PMID: 25709485; PMCID: PMC4330000.
22. Pavicic T, Sattler G, Fischer T, Dirschka T, Kerscher M, Gauglitz G, Dersch H, Kravtsov M, Heide I, Prager W. Calcium Hydroxyapatite Filler With Integral Lidocaine CaHA (+) for Soft Tissue Augmentation: Results from an Open-Label Multicenter Clinical Study. J Drugs Dermatol. 2022 May 1;21(5):481-487. doi: 10.36849/JDD.6737. PMID: 35533030.
23. Shumaker PR, Sakas EL, Swann MH, Greenway HT Jr. Calcium hydroxylapatite tissue filler discovered 6 years after implantation into the nasolabial fold: case report and review. Dermatol Surg. 2009 Feb;35 Suppl 1:375-9. doi: 10.1111/j.1524-4725.2008.01050.x. PMID: 19207328.
24. Thums MÁ, Payeras MR, Cherubini K, Koth VS, Salum FG. Clinical and Histological Effects of Calcium Hydroxyapatite Filler in the Orofacial Region: A Study in Rats. Dermatol Surg. 2024 Oct 1;50(10):939-945. doi: 10.1097/DSS.0000000000004260. Epub 2024 Jun 5. PMID: 38837772.
25. van Loghem J. Calcium Hydroxylapatite in Regenerative Aesthetics: Mechanistic Insights and Mode of Action. Aesthet Surg J. 2025 Mar 17;45(4):393-403. doi: 10.1093/asj/sjae196. PMID: 39365034.
26. Yutskovskaya YA, Kogan EA. Improved Neocollagenesis and Skin Mechanical Properties After Injection of Diluted Calcium Hydroxylapatite in the Neck and Décolletage:A Pilot Study. J Drugs Dermatol. 2017 Jan 1;16(1):68-74. PMID: 28095536.
27. Zerbinati N, Calligaro A. Calcium hydroxylapatite treatment of human skin: evidence of collagen turnover through picrosirius red staining and circularly polarized microscopy. Clin Cosmet Investig Dermatol. 2018 Jan 15;11:29-35. doi: 10.2147/CCID.S143015. PMID: 29391818; PMCID: PMC5772396.
28. Zerbinati N, D'Este E, Parodi PC, Calligaro A. Microscopic and ultrastructural evidences in human skin following calcium hydroxylapatite filler treatment. Arch Dermatol Res. 2017 Jul;309(5):389-396. doi: 10.1007/s00403-017-1734-3. Epub 2017 Mar 21. PMID: 28324170; PMCID: PMC5486564.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Barbara Zimnoch, Katarzyna Chmura, Katarzyna Rendaszka, Katarzyna Kowalska, Marta Pyziołek, Marta Bonarska, Paulina Kwaśniewska, Małgorzata Stróżna, Joanna Monika Najbar

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 5
Number of citations: 0